跳至主要内容
临床试验/JPRN-UMIN000053405
JPRN-UMIN000053405尚未招募Unknown

Molecular diagnostic characteristics in Cervical cancer: ROS1/ALK mutation biomarker study (MARC study) - MARC study

Japanes Gynecology Oncology Group0 个研究点目标入组 250 人开始时间: 2024年2月14日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1. Patients with active concomitant malignancy* except breast cancer. *Includes synchronous multiple cancer and metachronous multiple cancer with less than 5 years of disease-free survival. However, excludes skin basal cell carcinoma, skin squamous cell carcinoma, and any other curable lesions with local therapy such as carcinoma in situ or intramucosal carcinoma. 2. Patients who are diagnosed with any other acute/chronic, physically/mentally severe diseases and judged by the primary physician as inappropriate to enroll in this study because of safety reasons or any influence on study outcomes. 3. Any other cases that are inappropriate to enroll in this study, judged by the study principal investigator.

研究者

发起方
Japanes Gynecology Oncology Group

相似试验